Pharmerging Market, By Products (Pharmaceuticals, Healthcare and Others (IT and Record Management)), By Economy (Tier-1, Tier-2 and Tier-3), By Indication (Lifestyle Disease, Cancers & Autoimmune Diseases and Infectious Disease), By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, E-Commerce and Drug Stores), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Trends, Analysis and Forecast till 2030

The pharmaceutical industry was valued at US$971.94 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 6.10% to reach US$4426.72 billion by 2030.

A group of countries with strong economic growth and small market shares in the pharmaceutical industry is called "pharming." Among the key pharmaceutical market regions are China, India, Brazil, Russia, South Africa, Mexico, Indonesia, Turkey, and others. Three categories have been established for the pharmaceutical markets based on economic growth rates. Tier I comprises China, which controls the global pharmaceutical market due to significant public healthcare spending. Tier II consists of Russia, Brazil, and India. These countries have aging populations, rising consumer consciousness, and pro-business policies. Among the Tier III countries with the weakest market shares among developing countries are Indonesia, Thailand, Mexico, Turkey, Egypt, Vietnam, and South Africa.